TP53 and non-small cell lung carcinoma: A p53-status-determined prognostic relevance of interfering with PRC2 activity has been previously reported in Non-Small-Cell-Lung-Cancer (NSCLC) models, where PRC2 inhibition was efficient to prevent NSCLC formation in p53wt, but not in the p53mut context [72].